Japan Palliative Care Market

ID: MRFR/HC/47691-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026
Japan Palliative Care Market Research Report By Type (Hospital Inpatient Care, Hospice Inpatient Care, Nursing Homes, Residential Facility Care, Homecare, Private Residence Care), By End-User (Long Term Care Centers & Rehabilitation Centers, Hospitals & Clinics, Palliative Care Centers, Home Care Settings) and By Application (Cardiac Disease, Congestive Heart Failure, Cancer, Chronic Obstructive Pulmonary Disease (COPD), Kidney Failure, Alzheimer’s Disease, Parkinson’s Disease, Amyotrophic Lateral Sclerosis (ALS)) -Forecast to 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Japan Palliative Care Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)7.4%
2024 Market Size$ 164.1 Million
2025 Market Size$ 176.24 Million
2035 Market Size$ 360 Million

Key Players

VITAS Healthcare
Amedisys Inc
LHC Group
Brookdale Senior Living
Visiting Angels
Comfort Keepers
Opportunities
  • Aging Population and Chronic Illnesses
  • Cultural Shifts Towards End-of-Life Care
  • Technological Advancements in Healthcare
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Construction, BY Type (USD Million)
      1. 4.1.1 Hospital Inpatient Care
      2. 4.1.2 Hospice Inpatient Care
      3. 4.1.3 Nursing Homes
      4. 4.1.4 Residential Facility Care
      5. 4.1.5 Homecare
      6. 4.1.6 Private Residence Care
    2. 4.2 Construction, BY End-User (USD Million)
      1. 4.2.1 Long Term Care Centers & Rehabilitation Centers
      2. 4.2.2 Hospitals & Clinics
      3. 4.2.3 Palliative Care Centers
      4. 4.2.4 Home Care Settings
    3. 4.3 Construction, BY Application (USD Million)
      1. 4.3.1 Cardiac Disease
      2. 4.3.2 Congestive Heart Failure
      3. 4.3.3 Cancer
      4. 4.3.4 Chronic Obstructive Pulmonary Disease (COPD)
      5. 4.3.5 Kidney Failure
      6. 4.3.6 Alzheimer’s Disease
      7. 4.3.7 Parkinson’s Disease
      8. 4.3.8 Amyotrophic Lateral Sclerosis (ALS)
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Construction
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 VITAS Healthcare (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Amedisys Inc (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 LHC Group (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Brookdale Senior Living (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Visiting Angels (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Comfort Keepers (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Gentiva Health Services (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Curo Health Services (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 JAPAN MARKET ANALYSIS BY TYPE
    3. 6.3 JAPAN MARKET ANALYSIS BY END-USER
    4. 6.4 JAPAN MARKET ANALYSIS BY APPLICATION
    5. 6.5 KEY BUYING CRITERIA OF CONSTRUCTION
    6. 6.6 RESEARCH PROCESS OF MRFR
    7. 6.7 DRO ANALYSIS OF CONSTRUCTION
    8. 6.8 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
    9. 6.9 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
    10. 6.10 SUPPLY / VALUE CHAIN: CONSTRUCTION
    11. 6.11 CONSTRUCTION, BY TYPE, 2024 (% SHARE)
    12. 6.12 CONSTRUCTION, BY TYPE, 2024 TO 2035 (USD Million)
    13. 6.13 CONSTRUCTION, BY END-USER, 2024 (% SHARE)
    14. 6.14 CONSTRUCTION, BY END-USER, 2024 TO 2035 (USD Million)
    15. 6.15 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
    16. 6.16 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million)
    17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY END-USER, 2025-2035 (USD Million)
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Japan Construction Market Segmentation

Construction By Type (USD Million, 2025-2035)

  • Hospital Inpatient Care
  • Hospice Inpatient Care
  • Nursing Homes
  • Residential Facility Care
  • Homecare
  • Private Residence Care

Construction By End-User (USD Million, 2025-2035)

  • Long Term Care Centers & Rehabilitation Centers
  • Hospitals & Clinics
  • Palliative Care Centers
  • Home Care Settings

Construction By Application (USD Million, 2025-2035)

  • Cardiac Disease
  • Congestive Heart Failure
  • Cancer
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Kidney Failure
  • Alzheimer’s Disease
  • Parkinson’s Disease
  • Amyotrophic Lateral Sclerosis (ALS)